Dr. Timothy Hancock Dorius, MD
- Medicare services, 2024
- 33,094
- Medicare patients, 2024
- 405
- Part D claims, 2024
- 1,056
- Publications
- 2
- Clinical trials
- 9
- Practice address
- 8303 Dodge St, Omaha, NE 68114
- Practice phone
- Call (402) 354-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nebraska Methodist Hospital
Omaha, Nebraska
Find Dr. Dorius' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Timothy Hancock Dorius is a hematologist and oncologist in Omaha, Nebraska
Dr. Dorius practices at Nebraska Methodist Hospital in Omaha, Nebraska.
Dr. Dorius' NPI, 1689961484, was assigned on June 30, 2011. Dr. Dorius graduated from University of Oklahoma College of Medicine in 2011. Dr. Dorius holds Texas license R0853.
- NPI
- 1689961484NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5294952172
- NPI enumeration date
- June 30, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (402) 354-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Timothy Hancock Dorius practices at Nebraska Methodist Hospital in Omaha, Nebraska
Dr. Dorius' primary practice is Nebraska Methodist Hospital, at 8303 Dodge St, Omaha, NE 68114 in Douglas County. The practice phone is (402) 354-4000.
- Nebraska Methodist Hospital8303 Dodge St, Omaha, NE 68114 · Douglas CountyPhone(402) 354-4000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Timothy Hancock Dorius is affiliated with 6 sites of care and 2 medical groups
Dr. Dorius' primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dr. Dorius is also affiliated with Methodist Hospital. The medical group on file is Nebraska Cancer Specialists. Dmand AI also links Dr. Dorius to 3 more hospitals, 1 home health agency and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Timothy Hancock Dorius' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorius practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nebraska Methodist Hospital | Available with a free account |
| +5 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Timothy Hancock Dorius is one of 80 hematologists and oncologists in Nebraska
Hematology and oncology is Dr. Dorius' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Dorius' licenses on file in 2 states: Texas and Nebraska.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- Nebraska license
Hematologists and oncologists near Dr. Dorius
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Timothy Hancock Dorius billed Medicare for 33,094 services in 2024
CMS data shows 33,094 Medicare services from Dr. Dorius across 34 procedure codes in 2024, for 405 Medicare patients. Medicare paid $882,039 for them.
Dr. Dorius' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 45,7612024: 30,56233%
- Tests and treatments
- 2023: 2,0472024: 1,29437%
- Office and hospital visits
- 2023: 1,1002024: 1,0128%
- Other services
- 2023: 40,7702024: 129100%
- Lab and pathology
- 2023: 02024: 97
Where Dr. Dorius' Medicare services took place, 2024
- In an office32,988100%
- In a facility1060%
Dr. Dorius compared with the Nebraska median for hematologists and oncologists, 2024
- Dr. Dorius
- Nebraska median
- Medicare services
- 33,094vs 1,32225.0 times
- Medicare patients
- 405vs 408Close to median
- Part D claims
- 748vs 54936% above
Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Dorius' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Dorius?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Dorius and other hematologists and oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Timothy Hancock Dorius treated 405 Medicare patients in 2024, average age 75
CMS counts 405 Medicare patients who saw Dr. Dorius in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Dorius' median patient age at 66, with 62% women.
Dr. Dorius' Medicare patients by age, 2024
Dr. Dorius' Medicare patients by sex, 2024
- Women26966%
- Men13634%
Chronic conditions among Dr. Dorius' Medicare patients, 2024
- High blood pressure75%
- High cholesterol69%
- Cancer63%
- Arthritis52%
- Ischemic heart disease30%
- Chronic kidney disease28%
- Diabetes25%
- Mood disorders24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Dorius' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women62%
- Men37%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Timothy Hancock Dorius wrote 1,056 Medicare Part D claims in 2024
In 2024, Dr. Dorius wrote 1,056 Medicare Part D claims for 214 patients. 83% of them were for generic drugs. CMS names the drug for 748 of them, across 27 drugs with 11 or more claims each, at $1,464,986 in total drug cost. In 2023, CMS named 706 claims across 29 drugs.
Dr. Dorius' Part D claims by kind of drug, 2024
- Generic879 claims83%
- Brand-name177 claims17%
Dr. Dorius' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Dorius' Part D claims, 2024
- Opioids7%78 of 1,056 claims
- Antibiotics4%41 of 1,056 claims
- Antipsychotics, patients 65 and over1%13 of 1,056 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7062024: 7486%
Drugs named by CMS: 27 in 2024, 29 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Timothy Hancock Dorius offers telehealth to Medicare patients
Dr. Dorius accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dorius as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Timothy Hancock Dorius has 2 publications on record
Dmand AI links 2 papers to Dr. Dorius, published from 2015 to 2017. Dr. Dorius' most frequent co-authors are James O. Armitage, MD, Michael J. Baine, MD and Nathan Ronald Bennion, MD.
Dr. Dorius' most frequent co-authors
- James O. Armitage, MD1 shared paper
- Michael J. Baine, MD1 shared paper
- Nathan Ronald Bennion, MD1 shared paper
Recent publications by Dr. Dorius
Expert Rev Anticancer Ther
See who Dr. Dorius researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dorius works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Timothy Hancock Dorius has worked on 9 clinical trials
Dmand AI links Dr. Dorius to 9 clinical trials, 5 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Thoracic Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Dorius by phase
- 1Phase 1: 1 trial
- 5Phase 2: 5 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Dorius' trials
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Thoracic Neoplasms
- Carcinoma, Bronchogenic
- Adenocarcinoma of Lung
Investigators on the most trials with Dr. Dorius
- Erin R. Alesi, MD4 shared trials
- Aqeel Abbas Gillani, MD4 shared trials
- Laxmi Narayana Raju Buddharaju, MD3 shared trials
Recent clinical trials with Dr. Dorius
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC (opens in a new tab)
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial (opens in a new tab)
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Timothy Hancock Dorius received $26,151 in industry payments from 2016 to 2025
CMS Open Payments shows 526 general payments to Dr. Dorius from 75 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Gilead Sciences, Inc. paid the most, $12,166.
General payments to Dr. Dorius by program year, 2016 to 2025
General payments to Dr. Dorius by kind, 2016 to 2025
- Consulting fees$11,61045%
- Food and beverage$9,16335%
- Travel and lodging$2,4709%
- Honoraria$2,0488%
- Other$7263%
Companies that paid Dr. Dorius the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Timothy Hancock Dorius graduated from University of Oklahoma College of Medicine
Dr. Dorius graduated from University of Oklahoma College of Medicine in 2011.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Timothy Hancock Dorius's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Timothy Hancock Dorius
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Timothy Hancock Dorius' NPI number?
Dr. Timothy Hancock Dorius' NPI number is 1689961484. It was assigned on June 30, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Timothy Hancock Dorius?
Dr. Timothy Hancock Dorius is a hematologist and oncologist in Omaha, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Timothy Hancock Dorius practice?
Dr. Dorius practices at 8303 Dodge St, Omaha, NE 68114. Dr. Dorius' primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dmand AI also links Dr. Dorius to 3 hospitals, 1 home health agency and 1 medical group.
What is Dr. Timothy Hancock Dorius' office phone number?
The practice phone on file for Dr. Dorius is (402) 354-4000.
What is Dr. Timothy Hancock Dorius' medical license number?
Dr. Dorius holds Texas license R0853, one of the licenses on file in 2 states.
Which states has Dr. Timothy Hancock Dorius been licensed in?
Dmand AI has state licenses on file for Dr. Dorius in Texas and Nebraska.
Which hospitals is Dr. Timothy Hancock Dorius affiliated with?
Dr. Dorius is affiliated with Methodist Hospital. Dmand AI links Dr. Dorius to 3 more hospitals.
What medical group is Dr. Timothy Hancock Dorius part of?
Dr. Dorius is linked to Nebraska Cancer Specialists. Dmand AI links Dr. Dorius to 1 more medical group.
Does Dr. Timothy Hancock Dorius accept Medicare?
Yes. CMS data shows Dr. Dorius billed Medicare for 33,094 services in 2024, and Dr. Dorius accepts Medicare assignment.
Does Dr. Timothy Hancock Dorius offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Dorius as offering telehealth services.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Timothy Hancock Dorius see?
CMS counts 405 Medicare patients who saw Dr. Dorius in 2024, with an average age of 75.
What services does Dr. Timothy Hancock Dorius bill to Medicare?
In 2024, Dr. Dorius' most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J0897) and injected or infused drug (J1453).
Where did Dr. Timothy Hancock Dorius go to medical school?
Dr. Dorius graduated from University of Oklahoma College of Medicine in 2011.
What drugs does Dr. Timothy Hancock Dorius prescribe most?
In 2024 Medicare Part D data, Dr. Dorius' most prescribed drugs by claims were Anastrozole, Prednisone and Letrozole.
Has Dr. Timothy Hancock Dorius received payments from drug or device companies?
CMS Open Payments shows $26,151 in general payments to Dr. Dorius from 75 companies from 2016 to 2025. The largest total came from Gilead Sciences, Inc.
How long has Dr. Timothy Hancock Dorius been practicing?
Dr. Dorius graduated from medical school in 2011, 15 years ago.
Does Dr. Timothy Hancock Dorius do research?
Dmand AI links 2 publications to Dr. Dorius, published from 2015 to 2017. Dr. Dorius has worked on 9 clinical trials.
Who does Dr. Timothy Hancock Dorius publish with?
Dr. Dorius' most frequent co-authors are James O. Armitage, MD (1 shared paper), Michael J. Baine, MD (1 shared paper) and Nathan Ronald Bennion, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card